Literature DB >> 17320146

A high-throughput screening approach to anthrax lethal factor inhibition.

Sherida L Johnson1, Li-Hsing Chen, Maurizio Pellecchia.   

Abstract

A high-throughput screening approach was used to identify new inhibitors of the metallo-protease lethal factor from Bacillus anthracis. A library of approximately 14,000 compounds was screened using a fluorescence-based in vitro assay and hits were further characterized enzymatically via measurements of IC50 and Ki values against a small panel of metallo-proteases. This study led to the identification of new scaffolds that inhibit LF and the Botulinum Neurotoxin Type A in the low micromolar range, while sparing the human metallo-proteases MMP-2 and MMP-9. Therefore, these scaffolds could be further exploited for the development of potent and selective anti-toxin agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17320146      PMCID: PMC2020844          DOI: 10.1016/j.bioorg.2006.12.005

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  18 in total

Review 1.  Structure- and fragment-based approaches to protease inhibition.

Authors:  Sherida L Johnson; Maurizio Pellecchia
Journal:  Curr Top Med Chem       Date:  2006       Impact factor: 3.295

2.  A new role for old ligands: discerning chelators for zinc metalloproteinases.

Authors:  Faith E Jacobsen; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2006-03-15       Impact factor: 15.419

3.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes.

Authors:  M D Eldridge; C W Murray; T R Auton; G V Paolini; R P Mee
Journal:  J Comput Aided Mol Des       Date:  1997-09       Impact factor: 3.686

4.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

5.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

6.  Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  J Med Chem       Date:  2006-08-24       Impact factor: 7.446

7.  Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.

Authors:  Heather M Scobie; G Jonah A Rainey; Kenneth A Bradley; John A T Young
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

8.  Efficient synthetic inhibitors of anthrax lethal factor.

Authors:  Martino Forino; Sherida Johnson; Thiang Y Wong; Dmitri V Rozanov; Alexei Y Savinov; Wei Li; Roberto Fattorusso; Barbara Becattini; Andrew J Orry; Dawoon Jung; Ruben A Abagyan; Jeffrey W Smith; Ken Alibek; Robert C Liddington; Alex Y Strongin; Maurizio Pellecchia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

9.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

Authors:  David T Puerta; Jana A Lewis; Seth M Cohen
Journal:  J Am Chem Soc       Date:  2004-07-14       Impact factor: 15.419

View more
  12 in total

1.  Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor.

Authors:  Arpita Agrawal; César Augusto F de Oliveira; Yuhui Cheng; Jennifer A Jacobsen; J Andrew McCammon; Seth M Cohen
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

2.  Targeting metalloproteins by fragment-based lead discovery.

Authors:  Sherida Johnson; Elisa Barile; Biancamaria Farina; Angela Purves; Jun Wei; Li-Hsing Chen; Sergey Shiryaev; Ziming Zhang; Irina Rodionova; Arpita Agrawal; Seth M Cohen; Andrei Osterman; Alex Strongin; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2011-06-16       Impact factor: 2.817

3.  Development of a comprehensive, validated pharmacophore hypothesis for anthrax toxin lethal factor (LF) inhibitors using genetic algorithms, Pareto scoring, and structural biology.

Authors:  Ting-Lan Chiu; Elizabeth A Amin
Journal:  J Chem Inf Model       Date:  2012-06-25       Impact factor: 4.956

4.  Chelator fragment libraries for targeting metalloproteinases.

Authors:  Arpita Agrawal; Sherida L Johnson; Jennifer A Jacobsen; Melissa T Miller; Li-Hsing Chen; Maurizio Pellecchia; Seth M Cohen
Journal:  ChemMedChem       Date:  2010-02-01       Impact factor: 3.466

5.  Highly predictive support vector machine (SVM) models for anthrax toxin lethal factor (LF) inhibitors.

Authors:  Xia Zhang; Elizabeth Ambrose Amin
Journal:  J Mol Graph Model       Date:  2015-11-17       Impact factor: 2.518

6.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

7.  Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.

Authors:  Sherida L Johnson; Li-Hsing Chen; Elisa Barile; Aras Emdadi; Mojgan Sabet; Hongbin Yuan; Jun Wei; Donald Guiney; Maurizio Pellecchia
Journal:  Bioorg Med Chem       Date:  2009-03-26       Impact factor: 3.641

8.  Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.

Authors:  Ting-Lan Chiu; Jonathan Solberg; Satish Patil; Todd W Geders; Xia Zhang; Subhashree Rangarajan; Rawle Francis; Barry C Finzel; Michael A Walters; Derek J Hook; Elizabeth A Amin
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

9.  Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.

Authors:  Katerina Capková; Mark S Hixon; Sabine Pellett; Joseph T Barbieri; Eric A Johnson; Kim D Janda
Journal:  Bioorg Med Chem Lett       Date:  2009-10-31       Impact factor: 2.823

10.  Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.

Authors:  Alexander N Wein; Brian N Williams; Shihui Liu; Boris Ermolinsky; Daniele Provenzano; Ruben Abagyan; Andrew Orry; Stephen H Leppla; Michael Peredelchuk
Journal:  J Med Chem       Date:  2012-09-18       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.